Business Context and Reporting Period
Company: Novo Nordisk A/S
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: June 1, 2026
Subject: Update on Share Repurchase Programme
Novo Nordisk is a leading global healthcare company headquartered in Denmark, employing approximately 68,800 people across 80 countries. This filing reports on the execution of a share repurchase programme initiated on May 6, 2026, under the EU Market Abuse Regulation (MAR) Safe Harbour Rules.
Key Financial Metrics and Capital Allocation
This filing focuses on capital allocation via share buybacks rather than operational financial performance (revenue, profit, or cash flow).
| Metric | Value |
|---|---|
| Total Repurchase Programme Cap (12-month) | DKK 15 billion |
| Specific Programme Cap (May 6, 2026 – Feb 1, 2027) | DKK 11,200,000,010.45 |
| Total B Shares Repurchased (Since Feb 4, 2026) | 17,889,179 |
| Average Purchase Price (Since Feb 4, 2026) | DKK 263.47 |
| Total Transaction Value (Since Feb 4, 2026) | DKK 4,713,270,686 |
| Treasury Shares Held (Total) | 35,074,480 B shares (0.8% of share capital) |
| Total Outstanding Shares (A + B) | 4,465,000,000 |
Material Changes and Recent Activity
The filing details specific transactions executed between May 26 and May 29, 2026, under the programme initiated on May 6, 2026:
- May 26: 210,000 shares at DKK 288.13 (Value: DKK 60,506,846)
- May 27: 209,971 shares at DKK 286.16 (Value: DKK 60,085,467)
- May 28: 210,180 shares at DKK 287.85 (Value: DKK 60,500,695)
- May 29: 210,000 shares at DKK 293.42 (Value: DKK 61,617,382)
Accumulated transactions under the specific May 6 programme total 3,130,000 shares with a value of DKK 913,270,696.
Guidance, Outlook, and Risks
Outlook: Novo Nordisk expects to repurchase B shares for an amount up to DKK 15 billion during the 12-month period beginning February 4, 2026. As of May 29, 2026, approximately DKK 4.71 billion of this programme has been executed.
Risks and Contingencies: The filing does not disclose new operational risks, contingencies, or unusual items. It strictly adheres to regulatory reporting requirements for share buybacks.
Investor Verification Checklist
- Verify the remaining capacity of the DKK 15 billion repurchase programme (approx. DKK 10.29 billion remaining as of May 29, 2026).
- Confirm the current market price of B shares relative to the recent average purchase price of DKK 263.47.
- Review the total treasury share count (35,074,480) to assess the impact on earnings per share (EPS) dilution/accretion.
- Check the company website (novonordisk.com) for daily transaction details as required by the Safe Harbour Rules.